Theragnostic Talks: 6. Renaissance for radioligand therapy - with Germo Gericke

Theragnostic Talks: 6. Renaissance for radioligand therapy – with Germo Gericke

create 2021-05-25

Germo Gericke has been in the field of immunology and oncology since the early 90's. Now he is a medical officer at AAA (Advanced Accelerator Applications) and their former global head of research and development. What drives him? What, according to him, is the next big thing around the corner, speaking about theragnostics? And what's his opinion about more personalized treatment?

In this episode of Theragnostic Talks we talk a lot about what tomorrow’s cancer care will look like. Germo Gericke from AAA (Advanced Accelerator Applications) says that in five to ten years we are going to use theragnostics predominately in combination with other therapies. It gives us the opportunity to treat cancer in a totally different way.

Guest: Germo Gericke
By: Gustav Widar and Annette Andrén
Contact us: podcast@samnordic.se

You can also find the podcast on Google and Apple